Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and epidermal growth factor

1,3-dipropyl-8-cyclopentylxanthine has been researched along with epidermal growth factor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khoo, HE; Tan, CH; Tey, HB1
Canela, EI; Franco, R; Lluis, C; Mallol, J; Navarro, A; Zapata, R1

Other Studies

2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and epidermal growth factor

ArticleYear
Modulation of DNA synthesis via adenosine receptors in human epidermoid carcinoma (A431) cells.
    BioFactors (Oxford, England), 1994, Volume: 4, Issue:3-4

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Carcinoma, Squamous Cell; DNA, Neoplasm; Epidermal Growth Factor; Humans; Phenylisopropyladenosine; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Theophylline; Tumor Cells, Cultured; Xanthines

1994
Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitization and internalization of A1 adenosine receptors in a pituitary-derived cell line.
    Brain research, 1999, Jan-16, Volume: 816, Issue:1

    Topics: Adenosine; Animals; Calcium; Cell Division; Cell Line; Dactinomycin; Epidermal Growth Factor; Flow Cytometry; Immunohistochemistry; Pituitary Gland; Protein Synthesis Inhibitors; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Up-Regulation; Xanthines

1999